Skip to content
healthcare.dev

EPIOXA CROSS-LINKING

NDC 25357-024, riboflavin 5-phosphate ophthalmic, kit, from Glaukos Corporation.

Product NDC
25357-024
Status
Listed
Labeler
Glaukos Corporation
Dosage form
KIT
Route
OPHTHALMIC
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219910
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25357-024 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
25357-024-01253570024011 KIT in 1 CARTON (25357-024-01) * 1 SYRINGE, GLASS in 1 POUCH (25357-026-01) / 2 mL in 1 SYRINGE, GLASS * 1 SYRINGE, GLASS in 1 POUCH (25357-027-01) / 2 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/13cefc46-337c-41a3-b113-106bfe553bbb
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25357-024

Use it

Look up 25357-024 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25357-024 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25357-024. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.